Our study provides novel data on PCOS endocrinology; the supplementation of VD3 in PCOS rats decreased the plasma level of RARRES2 and the uterine expression of RARRES2, CMKLR1, and GPR1. The gene discussed is RARRES2; the disease is polycystic ovary syndrome.